Clinical trial

The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population

NCT01407419

Study summary

ClinicalTrials.gov

The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Treatment Acceleration Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Monthly Assessment Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-07-01

PhaseNA

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

Treatment AccelerationOTHER

Monthly AssessmentOTHER

Sponsors & collaborators

CorEvitaslead sponsor

Mapped research locations

AlbanyNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01407419 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.